← Back to headlines
Lilly and Novo Nordisk Win Antitrust Lawsuit Over GLP-1 Drug Market
Pharmaceutical giants Eli Lilly and Novo Nordisk have successfully defeated an antitrust lawsuit concerning their market position in GLP-1 drugs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
